Back To Search Instructions
Protocols
32 protocols meet the specified criteria
Disease Site: Other
Protocol No.TitleStatus
0100000331ANBL00B1: Neuroblastoma Biology StudiesOpen
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
1100000212Skin Cancer Institute Patient Registry and Tissue BankOpen
1100000610A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications (10-CBA)Open
1200000148A Multicenter Safety Study of Unlicensed Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients (6637-01)Open
1200000229Skin Cancer Prevention Program BiorepositoryOpen
1405319847My Life Our Future: A Hemophilia Genotyping Initiative Data and Sample Research RepositoryOpen
1406354010Continuation of a previously approved retrospective review, and a proposal to open a Propsective Registry for patients treated with the Xoft Axxent System device to track safety, efficacy, and cosmetic outcomes in patients with basal and squamous cell cancers.Open
1408448583The Use of In Vivo Confocal Microscopy In Normal and Pathological Cutaneous Lesions Open
1409505107Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated LightOpen
1412585986Clinical, Morphological, and Histological Effect of Emollient Application in Actinic KeratosesOpen
1412595351A RANDOMIZED PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN/METFORMIN (NSC#91485) VERSUS PACLITAXEL/CARBOPLATIN/PLACEBO AS INITIAL THERAPY FOR MEASURABLE STAGE III OR IVA, STAGE IVB, OR RECURRENT ENDOMETRIAL CANCER (GOG286b)Open
1502660379S1316: Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
1505875499Precision Medicine & Genomic Analyses Protocol for OncologyOpen
1512277664APEC14B1: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome StudyOpen
1603445994U1EMC27862: Pacific Sickle Cell Regional Collaborative Minimum Data SetOpen
1604498313Preclinical Investigation of Novel Therapeutic Agents for Hematological Malignancies Open
1606616633Phase Ib Trial of Pembrolizumab (MK-3475) in Combination with Dinaciclib (MK-7965) in Subjects with Hematologic Malignancies (KEYNOTE-155)Open
1606636273A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal CancerOpen
1608825367Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults with Multiple Myeloma to Drive Personalized Treatment DecisionsOpen
1609876907A Phase I/II Study of Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide and/or BendamustineOpen
1612049078A Phase I Multicenter, Open Label Study of Enadenotucirev Combined with PD-1 Inhibitor in Subjects with Metastatic or Advanced Epithelial TumorsOpen
1703266800A Phase 1b/2, Open-label, Multicenter, Dose Escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma Open
1704383758A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular MelanomaOpen
1705427831A prospective, randomized, blinded, placebocontrolled, phase IIb trial of an autologous tumor lysate (TL) + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC in stage III and stage IV (resected) melanoma to prevent recurrenceOpen
1706595817A MULTICENTER, TWO PART OPEN-LABEL, PHASE 1b CLINICAL STUDY OF CMP-001 ADMINISTERED EITHER IN COMBINATION WITH PEMBROLIZUMAB OR AS MONOTHERAPY IN SUBJECTS WITH ADVANCED MELANOMAOpen
1709802216Retrospective Review: Targeting hyperactive DNA break repair in glioblastomaOpen
PHXA-15-0002-10-15Can Diet and Physical Activity Modulate Ovarian Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Open
PHXA-17-0030-71-15A retrospective study on the outcome of patients with genitourinary (GU) malignancies who were treated at Dignity Health St. Joseph's Hospital and Medical Center (including University of Arizona Cancer Center at Dignity Health St. Joseph's)Open
PHXE-16-0205-80-15A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH - 1 (PD-1), IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMAOpen
PHXE-17-0117-80-15A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell LymphomaOpen
TESTCALENDAROpen